| 规格: | 98% |
| 分子量: | 302.2 |
| 包装 | 价格(元) |
| 500ug | 电议 |
| 1mg | 电议 |
| 5mg | 电议 |
Background:
Eltenac is a non-selective COX inhibitor (IC50= 0.03 µM for both COX-1 and COX-2 in isolated human whole blood) and a non-steroidal anti-inflammatory drug (NSAID).1In vivo, eltenac (1 mg/kg) reduces lameness in horses with tendinitis, pododermatitis, navicular disease, non-infectious arthritis, degenerative joint disease, phalanx fracture, and osteochondrosis.2It also reduces castration-induced edema in horses. Formulations containing eltenac have been used in the treatment of postoperative swelling in horses.
1.Klein, T., Dullweber, F., Brehm, C., et al.Characterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivoBiochem. Pharmacol.76(6)717-725(2008) 2.PrÜgner, W., Huber, R., and LÜhmann, R.Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspectsJ. Vet. Pharmacol. Ther.14(2)193-199(1991)
m.cnreagent.com